Cite
HARVARD Citation
Yoshikawa, A. et al. (2018). Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study. Modern rheumatology. 28 (2), pp. 227-234. [Online].